James Kihara, PRINCIPAL ACCOUNTING OFFICER at ACADIA PHARMACEUTICALS INC (ACAD), sold 1,327 shares at $14.60 ($19K) on 2025-05-02, disclosed to the SEC on 2025-05-02.
Scheduled sale ($19k) by PRINCIPAL ACCOUNTING OFFICER under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| ACAD | SELL | 2026-05-05 | $29K | — | Filing → |
| ACAD | SELL | 2026-04-07 | $23K | — | Filing → |
| ACAD | SELL | 2026-03-26 | $42K | — | Filing → |